These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 879361)

  • 1. Low levels of dopamine beta-hydroxylase and psychosis.
    Ewing JA; Mueller RA; Rouse BA; Silver D
    Am J Psychiatry; 1977 Aug; 134(8):927-8. PubMed ID: 879361
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram.
    Lake CR; Major LF; Ziegler MG; Kopin IJ
    Am J Psychiatry; 1977 Dec; 134(12):1411-4. PubMed ID: 920841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
    Sternberg DE; VanKammen DP; Lerner P; Bunney WE
    Science; 1982 Jun; 216(4553):1423-5. PubMed ID: 6124036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of prolonged disulfiram treatment on plasma dopamine-beta-hydroxylase activity in rhesus monkeys.
    Major LF; Lerner P; Dendel PS; Glaser L; Post RM
    J Stud Alcohol; 1982 Jan; 43(1):146-52. PubMed ID: 7109613
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of disulfiram and sodium diethyldithiocarbamate on tyrosine and dopamine-beta-hydroxylases activities in rat brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):153-9. PubMed ID: 239395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of disulfiram on serum dopamine-beta-hydroxylase and blood carbon disulphide concentrations in alcoholics.
    Caroldi S; De Paris P; Zotti S; Zanella I; Brugnone F
    J Appl Toxicol; 1994; 14(2):77-80. PubMed ID: 8027511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine-beta-hydroxylase inhibitor (disulfiram) on the response of adenohypophysis, serum ceruloplasmin and hypothalamic ascorbic acid to estradiol treatment.
    Schreiber V; Pribyl T; Jahodová J
    Endocrinol Exp; 1979 Sep; 13(3):131-8. PubMed ID: 315864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of plasma dopamine-beta-hydroxylase activity in patients with schizophrenia].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):193-7. PubMed ID: 7183426
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma copper and dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Perlman R; Levitt M; Meltzer H; Gruen R; Asnis L
    Biol Psychiatry; 1982 Jan; 17(1):115-20. PubMed ID: 7059633
    [No Abstract]   [Full Text] [Related]  

  • 10. Dependence of tyrosine and dopamine-beta-hydroxylases activities on disulfiram and diethyldithiocarbamate level in guinea pig brain and heart.
    Szmigielski A
    Pol J Pharmacol Pharm; 1975; 27(2):161-8. PubMed ID: 239396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat.
    Battista AF; Flamm ES; Goldstein M; Freedman LS
    J Neurosurg; 1976 Feb; 44(2):168-72. PubMed ID: 1245859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats.
    Amit Z; Levitan DE; Lindros KO
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):114-9. PubMed ID: 999391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can dopamine beta-hydroxylase levels predict adverse reactions to disulfiram?
    Ewing JA; Rouse BA; Mueller RA; Silver D
    Alcohol Clin Exp Res; 1978 Jan; 2(1):93-4. PubMed ID: 345861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control experiment in man on the sedative effect of disulfiram, an inhibitor of dopamine-beta-hydroxylase.
    Auriol B; Bardou E; Lambic C
    Biol Psychiatry; 1980 Aug; 15(4):623-5. PubMed ID: 7397293
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychotropic drugs as tools for clinical research into schizophrenia (author's transl)].
    Beckmann H
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Oct; 46(10):564-77. PubMed ID: 29831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
    DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
    Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum dopamine-beta-hydroxylase activity in schizophrenia.
    Meltzer HY; Nasr SJ; Tong C
    Biol Psychiatry; 1980 Oct; 15(5):781-8. PubMed ID: 6106516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma dopamine beta-hydroxylase activity in a North Swedish isolate with a high frequency of schizophrenia.
    Ross SB; Böök JA; Wetterberg L
    Clin Genet; 1981 May; 19(5):415-7. PubMed ID: 7296932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.